Activation of IGF2 seems to be a feature of all rhabdomyosarcomas, even though 11p15.5 loss of heterozygosity and IGF2 loss of imprinting are alterations predominantly associated with the embryonal and alveolar subtypes, respectively. Here, IGF2 is linked to rhabdomyosarcoma.